Skip to main content

Table 1 Subject demographics and neuropsychological assessments

From: Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers

 

SCD (n = 65)

NC (n = 73)

P value

Age (years)

65.85 (4.85)

64.55 (5.52)

.147

Education

11.86 (2.70)

11.68 (3.31)

.734

Gender (male/female)

23/42

38/35

.138

APOE ε4 (+/−)a

16/48

14/56

.443

MMSE

28.65 (1.23)

28.79 (1.38)

.866

MoCA-B

25.25 (2.36)

25.79 (2.48)

.338

AVLT-IR

6.50 (1.13)

6.66 (1.68)

.432

AVLT-DR

6.57 (1.84)

6.95 (2.20)

.166

AVLT-R

21.95 (1.74)

22.56 (1.46)

.005

STT-A

63.49 (16.42)

64.56 (22.94)

.112

STT-B

143.85 (37.44)

139.22 (37.24)

.913

AFT

17.88 (4.28)

18.81 (4.60)

.232

BNT

24.74 (2.45)

25.26 (3.14)

.396

GDS

3.35 (3.16)

1.89 (1.80)

.382

HAMD

5.66 (4.26)

2.51 (2.64)

< .001

HAMA

6.34 (4.70)

2.65 (2.43)

< .001

  1. APOE apolipoprotein E, MMSE Mini-Mental State Examination, MOCA-B Montreal Cognitive Assessment Basic Version, AVLT-IR Auditory Verbal Learning Test-immediate recall, AVLT-DR Auditory Verbal Learning Test-delay recall, AVLT-R Auditory Verbal Learning Test-recognition, STT-A Shape Trails Test Part A, STT-B Shape Trails Test Parts B, AFT semantic fluency (animals), BNT Boston Naming Test, GDS Geriatric Depression Scale, HAMD Hamilton Depression Rating Scale, HAMA Hamilton Anxiety Rating Scale
  2. aAPOE genotype results were included in SCD subjects (N = 64) and controls (N = 70)